Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

PSA regulates androgen receptor expression in prostate cancer cells.

Saxena P, Trerotola M, Wang T, Li J, Sayeed A, Vanoudenhove J, Adams DS, Fitzgerald TJ, Altieri DC, Languino LR.

Prostate. 2012 May 15;72(7):769-76. doi: 10.1002/pros.21482. Epub 2011 Sep 28.

2.

Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.

Liu X, Choi RY, Jawad SM, Arnold JT.

Prostate. 2011 May 15;71(7):766-77. doi: 10.1002/pros.21293. Epub 2010 Oct 28.

3.

Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.

Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.

Prostate. 2003 Mar 1;54(4):249-57.

PMID:
12539223
5.

The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.

Moss PE, Lyles BE, Stewart LV.

Exp Cell Res. 2010 Dec 10;316(20):3478-88. doi: 10.1016/j.yexcr.2010.09.015. Epub 2010 Oct 13.

6.
7.

A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.

Ben Jemaa A, Sallami S, Céraline J, Oueslati R.

Cell Biol Int. 2013 May;37(5):464-70. doi: 10.1002/cbin.10055. Epub 2013 Feb 18.

PMID:
23418075
8.

Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.

Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.

Cancer Res. 2004 Oct 1;64(19):7156-68.

10.

Identification of novel androgen receptor target genes in prostate cancer.

Jariwala U, Prescott J, Jia L, Barski A, Pregizer S, Cogan JP, Arasheben A, Tilley WD, Scher HI, Gerald WL, Buchanan G, Coetzee GA, Frenkel B.

Mol Cancer. 2007 Jun 6;6:39.

11.

Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway.

Lee SO, Lou W, Hou M, Onate SA, Gao AC.

Oncogene. 2003 Sep 11;22(39):7981-8.

PMID:
12970746
12.

Role of androgen receptor in the progression of human prostate tumor cells to androgen independence and insensitivity.

Kokontis JM, Hsu S, Chuu CP, Dang M, Fukuchi J, Hiipakka RA, Liao S.

Prostate. 2005 Dec 1;65(4):287-98.

PMID:
16015608
13.

Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.

Gong J, Zhu J, Goodman OB Jr, Pestell RG, Schlegel PN, Nanus DM, Shen R.

Oncogene. 2006 Mar 30;25(14):2011-21.

PMID:
16434977
14.

G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells.

Liu J, Youn H, Yang J, Du N, Liu J, Liu H, Li B.

Prostate. 2011 Sep;71(12):1276-86. doi: 10.1002/pros.21345. Epub 2011 Feb 9.

15.

LINE-1 ORF-1p functions as a novel androgen receptor co-activator and promotes the growth of human prostatic carcinoma cells.

Lu Y, Feng F, Yang Y, Gao X, Cui J, Zhang C, Zhang F, Xu Z, Qv J, Wang C, Zeng Z, Zhu Y, Yang Y.

Cell Signal. 2013 Feb;25(2):479-89. doi: 10.1016/j.cellsig.2012.11.004. Epub 2012 Nov 12.

PMID:
23153584
16.

Quantum dots-based multiplexed immunohistochemistry of protein expression in human prostate cancer cells.

Shi C, Zhou G, Zhu Y, Su Y, Cheng T, Zhau HE, Chung LW.

Eur J Histochem. 2008 Apr-Jun;52(2):127-34.

PMID:
18591159
17.

D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.

Kim SH, Singh SV.

Mol Cancer Ther. 2009 Jul;8(7):1946-54. doi: 10.1158/1535-7163.MCT-09-0104. Epub 2009 Jul 7.

18.

An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.

Paliouras M, Diamandis EP.

Biol Chem. 2008 Jun;389(6):773-80. doi: 10.1515/BC.2008.072.

PMID:
18627304
19.

Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression.

Cheng H, Snoek R, Ghaidi F, Cox ME, Rennie PS.

Cancer Res. 2006 Nov 1;66(21):10613-20.

20.

Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).

Koochekpour S, Lee TJ, Wang R, Culig Z, Delorme N, Caffey S, Marrero L, Aguirre J.

Prostate. 2007 Feb 1;67(2):178-89.

PMID:
17044040

Supplemental Content

Support Center